We are live on ! Find out more
QC

Quantedge Capital Portfolio holdings

AUM $183M
1-Year Est. Return 37.27%
This Fund
S&P 500
This Quarter Est. Return
+6.06%
1 Year Est. Return
+37.27%
3 Year Est. Return
+101.13%
5 Year Est. Return
+161.06%
10 Year Est. Return
AUM
$210M
AUM Growth
+$27.1M
Cap. Flow
+$27.8M
Cap. Flow %
13.23%
Top 10 Hldgs %
61.64%
Holding
96
New
28
Increased
21
Reduced
21
Closed
25

Top Buys

Rank Stock Value
1
BWA icon
BorgWarner
BWA
+$11.2M
2
PVH icon
PVH
PVH
+$9.36M
3
WYNN icon
Wynn Resorts
WYNN
+$5.8M
4
TNK icon
Teekay Tankers
TNK
+$4.99M
5
YELP icon
Yelp
YELP
+$4.98M

Sector Composition

Rank Sector Weight
1 Consumer Discretionary 40.87%
2 Consumer Staples 17.22%
3 Healthcare 16.42%
4 Industrials 4.64%
5 Energy 4.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
APH icon
51
Amphenol
APH
$212B
$500K 0.24%
+3,700
New +$495K
RPRX icon
52
Royalty Pharma
RPRX
$25.6B
$495K 0.24%
12,800
-34,800
-73% -$1.33M
LIVN icon
53
LivaNova
LIVN
$4.29B
$486K 0.23%
+7,900
New +$451K
RVT icon
54
Royce Value Trust
RVT
$2.29B
$481K 0.23%
29,900
-1,100
-4% -$17.6K
BSTZ icon
55
BlackRock Science and Technology Term Trust
BSTZ
$2.06B
$430K 0.2%
+19,000
New +$424K
TDF
56
Templeton Dragon Fund
TDF
$274M
$426K 0.2%
37,816
-1,700
-4% -$19.4K
ONT
57
Onterris Inc
ONT
$818M
$407K 0.19%
16,400
+7,000
+74% +$185K
KROS icon
58
Keros Therapeutics
KROS
$198M
$393K 0.19%
+19,292
New +$338K
NXST icon
59
Nexstar Media Group
NXST
$5.8B
$386K 0.18%
1,900
-11,400
-86% -$2.23M
TPC
60
Tutor Perini Cor
TPC
$4.45B
$382K 0.18%
+5,700
New +$374K
ALGN icon
61
Align Technology
ALGN
$12.5B
$312K 0.15%
+2,000
New +$287K
DIAX
62
DELISTED
Nuveen Dow 30SM Dynamic Overwrite Fund
DIAX
$287K 0.14%
18,800
+100
+0.5% +$1.49K
KNSA icon
63
Kiniksa Pharmaceuticals
KNSA
$6.09B
$270K 0.13%
6,545
-8,500
-56% -$341K
DCH
64
Dauch Corp
DCH
$1.42B
$258K 0.12%
40,200
+22,500
+127% +$140K
TVTX icon
65
Travere Therapeutics
TVTX
$5.84B
$252K 0.12%
+6,600
New +$215K
ASA
66
ASA Gold and Precious Metals
ASA
$1.03B
$241K 0.12%
4,047
-1,500
-27% -$76.1K
BC icon
67
Brunswick
BC
$5.43B
$215K 0.1%
+2,900
New +$197K
CAF
68
Morgan Stanley China A Share Fund
CAF
$321M
$210K 0.1%
12,070
-20,592
-63% -$343K
BXMX
69
DELISTED
Nuveen S&P 500 Buy-Write Income Fund
BXMX
$204K 0.1%
+13,900
New +$200K
NML
70
Neuberger Energy Infrastructure and Income Fund Inc
NML
$568M
$176K 0.08%
+20,761
New +$175K
TRIP icon
71
TripAdvisor
TRIP
$1.63B
$173K 0.08%
+11,900
New +$181K
AEF
72
abrdn Emerging Markets Equity Income Fund
AEF
$368M
-17,000
Closed -$110K
ALNY icon
73
Alnylam Pharmaceuticals
ALNY
$30.6B
-1,300
Closed -$593K
ANIP icon
74
ANI Pharmaceuticals
ANIP
$1.82B
-9,000
Closed -$824K
AVDL
75
DELISTED
Avadel Pharmaceuticals
AVDL
-22,300
Closed -$341K

Similar funds

Quantedge Capital's Q4 2025 Portfolio in Review

As of Q4 2025, Quantedge Capital held 96 positions worth $210M, up 15% from $183M the previous quarter. Its ten largest holdings account for 62% of the portfolio.

Quantedge Capital deployed $27.8M of net new capital in Q4 2025, opening 28 new positions and adding to 21 existing holdings. Its largest new stake was Wynn Resorts: 46,919 shares worth $5.65M.

By sector, the portfolio is most concentrated in Consumer Discretionary at 41% of assets, down from 41% a quarter earlier, followed by Consumer Staples and Healthcare.

On the sell side, the largest reduction was United Natural Foods, an estimated $6.75M trimmed.

  • Quantedge Capital's largest Q4 2025 buy was Wynn Resorts: 46,919 shares worth $5.65M.
  • Quantedge Capital added most to BorgWarner in Q4 2025, an estimated $11.2M increase.
  • Quantedge Capital's biggest Q4 2025 reduction was United Natural Foods, cutting an estimated $6.75M.
  • Quantedge Capital fully exited DNOW Inc in Q4 2025, selling an estimated $5.36M.
  • Quantedge Capital's ten largest holdings make up 62% of its $210M portfolio in Q4 2025.
  • Quantedge Capital opened 28 new positions and closed 25 in Q4 2025.
  • Quantedge Capital's portfolio value rose 15% quarter-over-quarter to $210M.

Based on Quantedge Capital's 13F filing for Q4 2025, filed 17 Feb 2026.